Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat ...

A sore throat or hoarseness that won’t improve could be more serious, according to Dr. Charles Johnson Jr., an ear, nose and throat (ENT) and head and neck surgeon. He ...

With a long list of successful procedures, published research and leadership positions on his resume, Dr. Rizwan Aslam could ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the Center for Drug Evaluation (CDE) o ...

Most salivary gland tumors are benign, and salivary gland cancers are uncommon malignancies that represent less than 5% of head and neck cancers. They are a heterogeneous group of tumors with varied ...

Special to IFN Iredell Physician Network and Iredell Health System are excited to announce the opening of Iredell Ear, Nose & ...

Adrenal carcinoma is a rare cancer that occurs in the adrenal glands. It’s typically treated surgically, sometimes alongside ...

The following is a summary of "Potential changes in microorganisms and metabolites associated with oral cancer: a preliminary study," published in the April 2025 issue of BMC Cancer by Wei et al. Oral ...

Mar. 13, 2025 — A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States ...